Home
Company
Products
Pharmacies
Newsroom >
Careers
Contact

 Home  |  Pharmacies  |  Contact 

Newsroom

Company Backgrounder

• Kowa Pharmaceuticals America: A legacy of trust. A future of care.

Press Releases

2009

• December 23, 2009 - Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
• December 14, 2009 - Kowa Pharmacueticals America Announces the Divestment of Cambia and PRO-571
• August 03, 2009 - FDA Approves LIVALO® for Primary Hypercholesterolemia and Combined Dyslipidemia
• June 22, 2009 - FDA Approves Cambia"! for Migraine
• April 14, 2009 - Kowa Pharmaceuticals America Announces Strategic Divestiture of Diclofenac Assets

2008

• August 4, 2008 - Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.

2007

• December 12, 2007 - ProEthic Pharmaceuticals Announces Acceptance of New Drug Application for Migraine
• October 2, 2007 - ProEthic Pharmaceuticals Announces U.S. Availability of Lipofen®
• July 12, 2007 - ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
• July 5, 2007 - ProEthic Pharmaceuticles Announces Filing of New Drug Application for Migraine Product Candidate
• June 8, 2007 - Proethic Pharmaceuticals Presents Positive Data for PRO-513 at American Headache Society Meeting
• January 8, 2007 - ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate

2006

• September 20, 2006 - ProEthic Pharmaceuticals Promotes Roger Graben to Vice President, Business Development
• June 14, 2006 - ProEthic Pharmaceuticals' Mark Elrod Named Best Sales Trainer at Fourth Annual American Business Awards
• May 25, 2006 - ProEthic Pharmaceuticals Named to Entrepreneur Magazine's 12th Annual Hot 100 Listing of the Fastest-Growing New Companies in the U.S.
• May 22, 2006 - ProEthic Pharmaceuticals Initiates Pivotal Phase III Trial for Fast-Acting Migraine Product Candidate
• March 7, 2006 - ProEthic Pharmaceuticals' CEO Carl Whatley Named '2006 Alabama Small Business Person of the Year'
• March 2, 2006 - ProEthic Pharmaceuticals Promotes William Maichle to Senior Vice President, Product Development and Technical Operations

2005

• November 3, 2005 - ProEthic Pharmaceuticals Completes Pre-IND Meetings on Two Fast-Acting Diclofenac Products
• September 13, 2005 - Swiss Drug Delivery Firm Licenses Fast-Acting Diclofenac Products to U.S. Based ProEthic Pharmaceutical
• July 29, 2005 - ProEthic Breaks Ground on New Facility
• May 18, 2005 - Montgomery, Alabama Business Places 26th in Entrepreneur Magazine's 'Hot 100'
• March 14, 2005 - ProEthic Pharmaceuticals, Inc Closes $24 Million Dollar Deal with Endo Pharmaceuticals, Inc
• January 11, 2005 - ProEthic Files IND for Transdermal NSAID Patch

2004

• May 12, 2004 - ProEthic Labs Taps Industry Veteran to Head Expanded Sales Force
• January 12, 2004 - ProEthic plans for growth

2003

• April 7, 2003 - U.S. and Swiss company sign agreement for once-daily transdermal version of Ketoprofen